0001209191-23-056981.txt : 20231130
0001209191-23-056981.hdr.sgml : 20231130
20231130170011
ACCESSION NUMBER: 0001209191-23-056981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231128
FILED AS OF DATE: 20231130
DATE AS OF CHANGE: 20231130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amello Jason
CENTRAL INDEX KEY: 0001451805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40629
FILM NUMBER: 231456493
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 01824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Candel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001841387
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522214851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 617-916-5445
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
FORMER COMPANY:
FORMER CONFORMED NAME: Candel Therapeutics, Inic.
DATE OF NAME CHANGE: 20210120
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-28
0
0001841387
Candel Therapeutics, Inc.
CADL
0001451805
Amello Jason
C/O CANDEL THERAPEUTICS, INC.
117 KENDRICK ST., SUITE 450
NEEDHAM
MA
02494
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-11-28
4
F
0
20153
0.90
D
202009
D
These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units.
/s/ Jason Amello
2023-11-30